Varenicline Treatment of Alcohol Dependence in Smokers
Conditions
Alcohol Abuse | Alcohol Dependence | Smoking
What is the purpose of this trial?
The purpose of the study is to determine whether Varenicline is effective in the treatment of alcohol dependence in smokers. Building upon knowledge about the role of nicotinic acetylcholine receptors in alcohol drinking and smoking, Varenicline, a smoking cessation treatment that targets these receptors, will be tested as a potential treatment for alcohol dependent smokers seeking alcohol treatment.
Participation Guidelines
- Age:
- 18 Years - 70 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Yale University
- Dates:
- September 2012 - December 2014
- Last Updated:
- Study HIC#:
- 1106008598
Clinicaltrials.gov ID: Yale1259075
